Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 93993.33% |
| Q2 2025 | 4.17% |
| Q1 2025 | 0.00% |
| Q4 2024 | -16.28% |
| Q3 2024 | 19.44% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | -26.53% |
| Q1 2023 | 100.25% |
| Q4 2022 | -87.40% |
| Q3 2022 | 2.48% |
| Q2 2022 | -22.40% |
| Q1 2022 | 20.96% |
| Q4 2021 | -180.30% |
| Q3 2021 | 31.04% |
| Q2 2021 | 7.12% |
| Q1 2021 | 18.72% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | -79.71% |
| Q1 2020 | 114.95% |
| Q4 2019 | 33.55% |
| Q3 2019 | -36.93% |
| Q2 2019 | 27.38% |
| Q1 2019 | -8.00% |
| Q4 2018 | -20.19% |
| Q3 2018 | -4.23% |
| Q2 2018 | -280.17% |
| Q1 2018 | 57.20% |
| Q4 2017 | -12.37% |
| Q3 2017 | 28.98% |
| Q2 2017 | -30.37% |
| Q1 2017 | -5815.63% |
| Q4 2016 | -77.93% |
| Q3 2016 | 17.89% |
| Q2 2016 | 30.16% |
| Q1 2016 | -6.90% |
| Q4 2015 | 367.11% |